These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1490488)

  • 1. Cross-over study of the bioavailability of a new NSAID (droxicam) versus piroxicam in healthy volunteers following single and multiple dose administration.
    Bartlett A; Costa A; Martinez L; Roser R; Sagarra R; Sanchez J
    Eur J Drug Metab Pharmacokinet; 1992; 17(3):195-9. PubMed ID: 1490488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers.
    Martínez L; Sánchez J; Roser R; García-Barbal J; Bartlett A; Estruch J; Sagarra R; Puig S; Costa A
    Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):729-37. PubMed ID: 3221746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of droxicam.
    Martínez L; Sánchez J
    Eur J Rheumatol Inflamm; 1991; 11(4):10-4. PubMed ID: 1365484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.
    Maya MT; Pais JP; Ruas Da Silva J; Morais JA
    Eur J Drug Metab Pharmacokinet; 1995; 20(4):275-9. PubMed ID: 8983932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single and multiple dose pharmacokinetics of a new NSAID (droxicam) in healthy volunteers.
    Martinez L; Sanchez J; Roser R; Garcia-Barbal J; Sagarra R; Bartlett A
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):303-7. PubMed ID: 2633925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of gastric emptying on droxicam pharmacokinetics.
    Sánchez J; Martínez L; García-Barbal J; Roser R; Bartlett A; Sagarra R
    J Clin Pharmacol; 1989 Aug; 29(8):739-45. PubMed ID: 2778095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of droxicam in rat and dog.
    Esteve A; Martínez L; Roser R; Sagarra R
    Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):423-9. PubMed ID: 3762266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers.
    Palma-Aguirre JA; Lopez-Gamboa M; Cariño L; Burke-Fraga V; González-de la Parra M
    Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antacid and ranitidine on droxicam pharmacokinetics.
    Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
    J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profile of piroxicam beta-cyclodextrin, in rat plasma and lymph.
    Kimura E; Bersani-Amado CA; Sudo LS; Santos SR; Oga S
    Gen Pharmacol; 1997 May; 28(5):695-8. PubMed ID: 9184804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-state dependent dissolution and oral bioavailability of piroxicam in rats.
    Lust A; Laidmäe I; Palo M; Meos A; Aaltonen J; Veski P; Heinämäki J; Kogermann K
    Eur J Pharm Sci; 2013 Jan; 48(1-2):47-54. PubMed ID: 23085546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence of two oral dosage forms prepared from different polymorphic modifications of tenoxicam.
    Salem MS; Alkaysi HN; Gharaibeh AM; Gharaibeh NM; Badwan AA
    J Clin Pharm Ther; 1994 Jun; 19(3):203-7. PubMed ID: 7962225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical trial comparing a new NSAID (droxicam) and piroxicam in spinal osteoarthritis.
    Bohl D; Gausmann H; Vorberg G; Sánchez J; García-Barbal R; Sarti JF; Harrison FJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):416-9. PubMed ID: 2258250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid method for the determination of piroxicam in plasma by high-performance liquid chromatography.
    Maya MT; Pais JP; Morais JA
    J Pharm Biomed Anal; 1995 Mar; 13(3):319-22. PubMed ID: 7619893
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanoemulsifying drug delivery system to improve the bioavailability of piroxicam.
    Motawea A; Borg T; Tarshoby M; Abd El-Gawad AE
    Pharm Dev Technol; 2017 May; 22(3):445-456. PubMed ID: 27583581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose pharmacokinetics of piroxicam in cats.
    Heeb HL; Chun R; Koch DE; Goatley MA; Hunter RP
    J Vet Pharmacol Ther; 2003 Aug; 26(4):259-63. PubMed ID: 12887607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions.
    Deroubaix X; Stockis A; Allemon AM; Lebacq E; Acerbi D; Ventura P
    Eur J Clin Pharmacol; 1995; 47(6):531-6. PubMed ID: 7768257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHARMACOKINETICS OF PIROXICAM IN CRANES (FAMILY GRUIDAE).
    Keiper NL; Cox SK; Doss GA; Elsmo B; Franzen-Klein D; Hartup BK
    J Zoo Wildl Med; 2017 Sep; 48(3):886-890. PubMed ID: 28920805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piroxicam immediate release formulations: A fasting randomized open-label crossover bioequivalence study in healthy volunteers.
    Helmy SA; El-Bedaiwy HM
    Clin Pharmacol Drug Dev; 2014 Nov; 3(6):466-71. PubMed ID: 27129120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.